The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
The benefits and harms of breast cancer screening: an independent review: A report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012.
Open accessAbstract
1.1 Introduction The breast cancer screening programmes in the United Kingdom currently invite women aged 50–70 years for screening mammography every 3 years. Since the time the screening programmes were established, there has been debate, at times sharply polarised, over the magnitude of their benefit and harm, and the balance between them. The expected major benefit is reduction in mortality from breast cancer. The major harm is overdiagnosis and its consequences; overdiagnosis refers to the detection of cancers on screening, which would not have become clinically apparent in the woman’s lifetime in the absence of screening. Professor Sir Mike Richards, National Cancer Director, England, and Dr Harpal Kumar, Chief Executive Officer of Cancer Research UK, asked Professor Sir Michael Marmot to convene and chair an independent panel to review the evidence on benefits and harms of breast screening in the context of the UK breast screening programmes. The panel, authors of this report, reviewed the extensive literature and heard testimony from experts in the field who were the main contributors to the debate. The nature of information communicated to the public, which too has sparked debate, was not part of the terms of reference of the panel, which are listed in Appendix 1 . 1.2 Relative mortality benefit The purpose of screening is to advance the time of diagnosis so that prognosis can be improved by earlier intervention. A consequence of earlier diagnosis is that it increases the apparent incidence of breast cancer in a screened population and extends the average time from diagnosis to death, even if screening were to confer no benefit. The appropriate measure of benefit, therefore, is reduction in mortality from breast cancer in women offered screening compared with women not offered screening. In the panel’s judgement, the best evidence for the relative benefit of screening on mortality reduction comes from 11 randomised controlled trials (RCTs) of breast screening. Meta-analysis of these trials with 13 years of follow-up estimated a 20% reduction in breast cancer mortality in women invited for screening. The relative reduction in mortality will be higher for women actually attending screening, but by how much is difficult to say because women who do not attend are likely to have a different background risk. Three types of uncertainties surround this estimate of 20% reduction in breast cancer mortality. The first is statistical: the 95% confidence interval (CI) around the relative risk (RR) reduction of 20% was 11–27%. The second is bias: there are a number of potential sources of distortion in the trials that have been widely discussed in the literature ranging from suboptimal randomisation to problems in adjudicating cause of death. The third is the relevance of these old trials to the current screening programmes. The panel acknowledged these uncertainties, but concluded that a 20% reduction is still the most reasonable estimate of the effect of the current UK screening programmes on breast cancer mortality. Most other reviews of the RCTs have yielded similar estimates of relative benefit. The RCTs were all conducted at least 20–30 years ago. More contemporary estimates of the benefit of breast cancer screening come from observational studies. The panel reviewed three types of observational studies. The first were ecological studies comparing areas, or time periods, when screening programmes were and were not in place. These have generated diverse findings, partly because of the major advances in treatment of breast cancer, which have a demonstrably larger influence on mortality trends than does screening, and partly because of the difficulty of excluding imbalances in other factors that could affect breast cancer mortality. The panel did not consider these studies helpful in estimating the effect of screening on mortality. The other two types of studies, case–control studies and incidence-based mortality studies, showed breast screening to confer a greater benefit than did the trials. Although these studies, in general, attempted to control for non-comparability of screened and unscreened women, the panel was concerned that residual bias could inflate the estimate of benefit. However, the panel notes that these studies’ findings are in the same direction as the trials. 1.3 Absolute mortality benefit Estimates of absolute benefit of screening have varied from one breast cancer death avoided for 2000 women invited to screening to 1 avoided for about 100 women screened, about a 20-fold difference. Major determinants of that large variation are the age of women screened, and the durations of screening and follow-up. The age of the women invited is important, as mortality from breast cancer increases markedly with age. The panel therefore applied the relative mortality reduction of 20% to achieve the observed cumulative absolute risk of breast cancer mortality over the ages 55–79 years for women in the Uni
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness
Tengs, T. O., Adams, M. E., Pliskin, J. S., Safran, D. G., Siegel, J. E., Weinstein, M. C., & Graham, J. D. (1995) · Risk Analysis · doi:10.1111/j.1539-6924.1995.tb00330.x · Cited by 1,321
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., & Hartwell, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1041 · Cited by 1,155
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Schoen, R. E., Pinsky, P. F., Weissfeld, J. L., Yokochi, L. A., Church, T., Laiyemo, A. O., Bresalier, R., Andriole, G. L., Buys, S. S., Crawford, E. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114635 · Cited by 1,021
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Ovarian cancer and hormone replacement therapy in the Million Women Study
Beral, V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60534-0 · Cited by 937
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., & Sigfússon, B. (1988) · BMJ · doi:10.1136/bmj.297.6654.943 · Cited by 916
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Ten- to Fourteen-Year Effect of Screening on Breast Cancer Mortality 2
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/69.2.349 · Cited by 840
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Tabár, L., Vitak, B., Chen, T. H.-H., Yen, A. M.-F., Cohen, A., Tot, T., Chiu, S. Y.-H., Chen, S. L.-S., Fann, J. C.-Y., Rosell, J., et al. (2011) · Radiology · doi:10.1148/radiol.11110469 · Cited by 791
Trends in Cancer Incidence, Survival and Mortality
Estève, J., & Coleman, M. (2009) · Husband and Reznek's Imaging in Oncology, Third Edition · doi:10.3109/9780415874984-2 · Cited by 761
The Coronary Drug Project Research Group (1980) · New England Journal of Medicine · doi:10.1056/nejm198010303031804 · Cited by 659
UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
Peto, R., Boreham, J., Clarke, M., Davies, C., & Beral, V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02277-7 · Cited by 648
Kesson, E. M., Allardice, G. M., George, W. D., Burns, H. J. G., & Morrison, D. S. (2012) · BMJ · doi:10.1136/bmj.e2718 · Cited by 579
Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., Frank, P. G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U. E., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12731 · Cited by 576
Quinn, M., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
Cuzick, J., Sestak, I., Pinder, S. E., Ellis, I. O., Forsyth, S., Bundred, N. J., Forbes, J. F., Bishop, H., Fentiman, I. S., & George, W. D. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70266-7 · Cited by 567
Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer
Giordano, S. H., Kuo, Y.-F., Freeman, J. L., Buchholz, T. A., Hortobagyi, G. N., & Goodwin, J. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji067 · Cited by 552
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Rethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts
Preston, D. L., Mattsson, A., Holmberg, E., Shore, R., Hildreth, N. G., & Boice, J. D. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0220:reobcr]2.0.co;2 · Cited by 512
Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
Logan, R. F. A., Patnick, J., Nickerson, C., Coleman, L., Rutter, M. D., & von Wagner, C. (2012) · Gut · doi:10.1136/gutjnl-2011-300843 · Cited by 506
Moss, S. M., Cuckle, H., Evans, A., Johns, L., Waller, M., & Bobrow, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69834-6 · Cited by 503
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY
Verbeek, A. L. M., Holland, R., Sturmans, F., Hendriks, J. H. C. L., Avunac, M., & Day, N. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91703-3 · Cited by 495
Sanders, M. E., Schuyler, P. A., Dupont, W. D., & Page, D. L. (2005) · Cancer · doi:10.1002/cncr.21069 · Cited by 485
Glass, A. G., Lacey, J. V., Carreon, J. D., & Hoover, R. N. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm059 · Cited by 439
Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M. (2010) · BMJ · doi:10.1136/bmj.c3620 · Cited by 412
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012082 · Cited by 407
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
The randomized trials of breast cancer screening: what have we learned?
Smith, R. A., Duffy, S. W., Gabe, R., Tabar, L., Yen, A. M. F., & Chen, T. H. H. (2004) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.06.014 · Cited by 380
Psychosocial aspects of mastectomy: I. the women's perspective
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.4.432 · Cited by 365
Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
Fisher, B., Gündüz, N., Coyle, J., Rudock, C., & Saffer, E. (1989) · PubMed · Cited by 361
Green, J., Cairns, B. J., Casabonne, D., Wright, F. L., Reeves, G., & Beral, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70154-1 · Cited by 357
Puffer, S., Torgerson, D., & Watson, J. (2003) · BMJ · doi:10.1136/bmj.327.7418.785 · Cited by 351
Recommendations on screening for breast cancer in average-risk women aged 40-74 years
The Canadian Task Force on Preventive Health Care (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110334 · Cited by 348
Welch, H. G., & Black, W. C. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00014 · Cited by 348
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Otto, S. J., Fracheboud, J., Looman, C. W., Broeders, M. J., Boer, R., Hendriks, J. H., Verbeek, A. L., & de Koning, H. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13132-7 · Cited by 333
Comparison of Screening Mammography in the United States and the United Kingdom
Smith-Bindman, R. (2003) · JAMA · doi:10.1001/jama.290.16.2129 · Cited by 314
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub4 · Cited by 311
ADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS
CUZICK, J., EDWARDS, R., & SEGNAN, N. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970515)16:9<1017::aid-sim508>3.0.co;2-v · Cited by 309
Canadian Task Force on Preventive Health Care
back, W., Birtwhistle, R., Fcfp, C., Pottie, K. C., MClSc, Shaw, E. A., Dickinson, J. A., Brauer, P. M., Fortin, M., Bell, N. R., et al. (2012) · Cited by 303
Chu, K. C., Smart, C. R., & Tarone, R. E. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.14.1125 · Cited by 302
Autier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Long-term toxic effects of adjuvant chemotherapy in breast cancer
Azim, H. A., de Azambuja, E., Colozza, M., Bines, J., & Piccart, M. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq683 · Cited by 292
Reeves, G. K., Beral, V., Green, J., Gathani, T., & Bull, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70911-1 · Cited by 284
Moser, K., Patnick, J., & Beral, V. (2009) · BMJ · doi:10.1136/bmj.b2025 · Cited by 282
The Natural History of Invasive Breast Cancers Detected by Screening Mammography
Zahl, P.-H., Mæhlen, J., & Welch, H. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2311 · Cited by 261
The Swedish Organised Service Screening Evaluation Group (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0349 · Cited by 258
Kalager, M., Adami, H.-O., Bretthauer, M., & Tamimi, R. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00005 · Cited by 243
Duffy, S. W., Tabar, L., Olsen, A. H., Vitak, B., Allgood, P. C., Chen, T. H. H., Yen, A. M. F., & Smith, R. A. (2010) · Journal of Medical Screening · doi:10.1258/jms.2009.009094 · Cited by 240
Zamiri, I. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91802-7 · Cited by 232
Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
Kerlikowske, K., Cook, A. J., Buist, D. S. M., Cummings, S. R., Vachon, C., Vacek, P., & Miglioretti, D. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4770 · Cited by 224
Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012077 · Cited by 203
Biesheuvel, C., Barratt, A., Howard, K., Houssami, N., & Irwig, L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70380-7 · Cited by 196
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub3 · Cited by 194
Brett, J., & Austoker, J. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.292 · Cited by 189
Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
de Gelder, R., Heijnsdijk, E. A. M., van Ravesteyn, N. T., Fracheboud, J., Draisma, G., & de Koning, H. J. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr009 · Cited by 185
Njor, S., Nyström, L., Moss, S., Paci, E., Broeders, M., Segnan, N., & Lynge, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012080 · Cited by 185
Systematic review of the psychological consequences of false-positive screening mammograms
Bond, M., Pavey, T., Welch, K., Cooper, C., Garside, R., Dean, S., & Hyde, C. (2013) · Health Technol Assess · doi:10.3310/hta17130 · Cited by 184
Mammographic Screening Programmes in Europe: Organization, Coverage and Participation
Giordano, L., Von Karsa, L., Tomatis, M., Majek, O., De Wolf, C., Lancucki, L., Hofvind, S., Nystrom, L., Segnan, N., & Ponti, A. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012085 · Cited by 178
Suicides among Danish cancer patients 1971–1999
Yousaf, U., Christensen, M.-L., Engholm, G., & Storm, H. H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602424 · Cited by 174
How effective are breast cancer screening programmes by mammography? Review of the current evidence
Schopper, D., & de Wolf, C. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.022 · Cited by 169
Hakama, M., Pukkala, E., HeikkilÄ, M., & Kallio, M. (1997) · BMJ · doi:10.1136/bmj.314.7084.864 · Cited by 161
Brett, J., Austoker, J., & Ong, G. (1998) · Journal of Public Health · doi:10.1093/oxfordjournals.pubmed.a024793 · Cited by 142
Correcting for Non-Compliance Bias in Case–Control Studies to Evaluate Cancer Screening Programmes
Duffy, S. W., Cuzick, J. M., Tabár, L. K., Viták, B., Chen, T. H.-H., Yen, M., & Smith, R. A. (2002) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00266 · Cited by 138
Psychological Consequences of Screening Mammography
Cockburn, J., Staples, M., Hurley, S. F., & Luise, T. D. (1994) · Journal of Medical Screening · doi:10.1177/096914139400100104 · Cited by 132
Suicide After Breast Cancer: an International Population-Based Study of 723 810 Women
Schairer, C., Brown, L. M., Chen, B. E., Howard, R. A., Lynch, C. F., Hall, P. N., Storm, H. H., Pukkala, E., Anderson, A., Kaijser, M., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj377 · Cited by 132
Zackrisson, S., Andersson, I., Manjer, J., & Janzon, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11622 · Cited by 130
Travis, R. C., REEVES, G. K., Green, J., Bull, D., Tipper, S. J., Baker, K., Beral, V., Peto, R., Bell, J. I., Zélénika, D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60636-8 · Cited by 129
Autier, P., Héry, C., Haukka, J. K., Boniol, M., & Byrnes, G. B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7041 · Cited by 128
On the efficacy of screening for breast cancer
Freedman, D. A. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyg275 · Cited by 128
Advanced breast cancer incidence following population-based mammographic screening
Autier, P., Boniol, M., Middleton, R., Doré, J., Héry, C., Zheng, T., & Gavin, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq633 · Cited by 126
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography
Morrell, S. L., Barratt, A. L., Irwig, L., Howard, K., Biesheuvel, C., & Armstrong, B. K. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9459-z · Cited by 123
Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
Cameron, D., Massie, C. E., Kerr, G. R., & Leonard, R. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601366 · Cited by 117
Self-citationRetsky, M. W., Demicheli, R., Hrushesky, W. J. M., Baum, M., & Gukas, I. D. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.00990.x · Cited by 116
Screening Mammography — A Long Run for a Short Slide?
Welch, H. G. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008369 · Cited by 113
REEVES, G. K., Travis, R. C., Green, J., Bull, D., Tipper, S. J., Baker, K., Beral, V., Peto, R., Bell, J. I., Zélénika, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.1042 · Cited by 109
Screening for breast cancer in England: past and future
(2006) · Journal of Medical Screening · doi:10.1258/096914106777589678 · Cited by 109
Overdiagnosis in Screening: Is the Increase in Breast Cancer Incidence Rates a Cause for Concern ?
Paci, E., Warwick, J., Falini, P., & Duffy, S. W. (2004) · Journal of Medical Screening · doi:10.1177/096914130301100106 · Cited by 108
Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer
White, E. E., Miglioretti, D. L., Yankaskas, B. C., Geller, B. M., Rosenberg, R. D., Kerlikowske, K. M., Saba, L. M., Vacek, P. M., Carney, P. A., Buist, D. S. M., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh337 · Cited by 106
Jonsson, H., Nyström, L., Törnberg, S., & Lenner, P. (2001) · Journal of Medical Screening · doi:10.1136/jms.8.3.152 · Cited by 105
Zbuk, K. M., & Anand, S. S. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.083774 · Cited by 103
Gilbert, F. J., Cordiner, C., Affleck, I. R., Hood, D. B., Mathieson, D., & Walker, L. G. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00294-9 · Cited by 102
Impact of Mammography Detection on the Course of Breast Cancer in Women Aged 40–49 Years
Malmgren, J. A., Parikh, J. R., Atwood, M. K., & Kaplan, H. G. (2012) · Radiology · doi:10.1148/radiol.11111734 · Cited by 99
Long term effects of tamoxifen on blood lipid values in breast cancer.
Dewar, J. A., Horobin, J. M., PREECE, P. E., Tavendale, R., Tunstall‐Pedoe, H., & Wood, R. A. (1992) · BMJ · doi:10.1136/bmj.305.6847.225 · Cited by 94
Self-citationREEVES, G. K., Pirie, K. L., Green, J., Bull, D., Beral, V., & Collaborators, F. T. M. W. S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26460 · Cited by 90
Overdiagnosis in organised mammography screening in Denmark. A comparative study
Jørgensen, K. J., Zahl, P. H., & Gøtzsche, P. C. (2009) · BMC Women s Health · doi:10.1186/1472-6874-9-36 · Cited by 88
Mammography screening: truth, lies, and controversy
Gøtzsche, P. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61216-1 · Cited by 88
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
Esserman, L. J., Shieh, Y., Rutgers, E. J. T., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1748-z · Cited by 86
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction
the IMPACT Working Group, Puliti, D., Miccinesi, G., Collina, N., Lisi, V. D., Federico, M., Ferretti, S., Finarelli, A. C., Foca, F., Mangone, L., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604532 · Cited by 85
The frequency of breast cancer screening
(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00397-5 · Cited by 78
Demissie, K., Mills, O. F., & Rhoads, G. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00243-6 · Cited by 76
The 2009 Breast Cancer Screening Recommendations of the US Preventive Services Task Force
Woolf, S. H. (2010) · JAMA · doi:10.1001/jama.2009.1989 · Cited by 75
Psychological consequences of false-positive screening mammograms in the UK
Bond, M., Pavey, T., Welch, K., Cooper, C., Garside, R., Dean, S. G., & Hyde, C. (2012) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2012-100608 · Cited by 73
Comparison of the coding of death certificates related to cancer in seven countries.
Percy, C., & DOLMAN, A. (1978) · PubMed · Cited by 71
Hormone therapy and breast cancer risk 10 years after the WHI
Gompel, A., & Santen, R. J. (2012) · Climacteric · doi:10.3109/13697137.2012.666456 · Cited by 70
Measuring effects without randomized trials? Options, problems, challenges.
Moses, L. E. (1995) · PubMed · Cited by 67
Psychosocial and sexual impact of diagnosis and treatment of breast cancer
Fallowfield, L. J., & Hall, A. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072478 · Cited by 64
Castelló-Cros, R., Bonuccelli, G., Molchansky, A., Capozza, F., Witkiewicz, A. K., Birbe, R., Howell, A., Pestell, R. G., Whitaker‐Menezes, D., Sotgia, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.12.16002 · Cited by 62
Acute Wounds Accelerate Tumorigenesis by a T Cell–Dependent Mechanism
Stuelten, C. H., Barbul, A., Busch, J. I., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1842 · Cited by 60
Wallis, M., Clements, K., Kearins, O., Ball, G., Macartney, J., & Lawrence, G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.151 · Cited by 58
Breast cancer screening for women ages 50 to 69years a systematic review of observational evidence
Harris, R., Yeatts, J., & Kinsinger, L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.07.004 · Cited by 57
Seigneurin, A., François, O., Labarère, J., Oudeville, P., Monlong, J., & Colonna, M. (2011) · BMJ · doi:10.1136/bmj.d7017 · Cited by 56
Digital mammography screening: Weighing reduced mortality against increased overdiagnosis
de Gelder, R., Fracheboud, J., Heijnsdijk, E. A. M., et al. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.06.009 · Cited by 55
Moss, S. M., Summerley, M. E., Thomas, B., Ellman, R., & Chamberlain, J. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.4.362 · Cited by 54
Magnus, M. C., Ma, P., Shen, M. M., Bourgeois, J. P., & Magnus, J. H. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2098 · Cited by 53
Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort
collaborators, F. T. M. W. S., Green, J., Roddam, A., Pirie, K. L., Kirichek, O., REEVES, G. K., & Beral, V. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.525 · Cited by 52
Mammography benefit in the Canadian National Breast Screening Study‐2: A model evaluation
Rijnsburger, A. J., van Oortmarssen, G. J., Boer, R., Draisma, G., To, T. M., Miller, A. B., & de Koning, H. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20143 · Cited by 52
Overdiagnosis in Breast Cancer Screening: Time to Tackle an Underappreciated Harm
Elmore, J. G., & Fletcher, S. W. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00012 · Cited by 52
Trends in breast cancer incidence, survival, and mortality
Coleman, M. P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02593-9 · Cited by 51
Weedon‐Fekjær, H., Bakken, K. S., VATTEN, L. J., & Tretli, S. (2012) · BMJ · doi:10.1136/bmj.e299 · Cited by 50
Suhrke, P., Mæhlen, J., Schlichting, E., et al. (2011) · BMJ · doi:10.1136/bmj.d4692 · Cited by 48
Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases
Willis, L., Alarcón, T., Elia, G., Jones, J. L., Wright, N. A., Tomlinson, I. P. M., Graham, T. A., & Page, K. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3144 · Cited by 47
Predicting the impact of the screening programme for colorectal cancer in the UK
Parkin, D. M., Tappenden, P., Olsen, A. H., Patnick, J., & Sasieni, P. D. (2008) · Journal of Medical Screening · doi:10.1258/jms.2008.008024 · Cited by 47
Time interval since last test in a breast cancer screening programme: a case-control study in Italy.
Palli, D., Turco, M. R. D., Buiatti, E., Ciatto, S., Crocetti, E., & Paci, E. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.3.241 · Cited by 47
Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening
Caldarella, A., Puliti, D., Crocetti, E., Bianchi, S., Vezzosi, V., Apicella, P., Biancalani, M., Giannini, A., Urso, C., Zolfanelli, F., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1304-1 · Cited by 46
Balancing harms and benefits of service mammography screening programs: a cohort study
Puliti, D., Miccinesi, G., Zappa, M., Manneschi, G., Crocetti, E., & Paci, E. (2012) · Breast Cancer Research · doi:10.1186/bcr3090 · Cited by 45
Breast Cancer Screening: A 35-Year Perspective
Fletcher, S. W. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr003 · Cited by 44
Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets
Eilbert, K. W., Carroll, K. T., Peach, J., Khatoon, S., Basnett, I., & McCulloch, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605393 · Cited by 44
Does an organised screening programme reduce the inequalities in breast cancer survival?
Puliti, D., Miccinesi, G., Manneschi, G., Buzzoni, C., Crocetti, E., Paci, E., & Zappa, M. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr121 · Cited by 44
Measuring Mortality Reductions in Cancer Screening Trials
Hanley, J. A. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq021 · Cited by 42
Junod, B., Zahl, P., Kaplan, R. M., Olsen, J., & Greenland, S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-401 · Cited by 41
Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?
Gompel, A., & Plu‐Bureau, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05664.x · Cited by 40
Zackrisson, S., Janzon, L., Manjer, J., & Andersson, I. (2007) · Journal of Medical Screening · doi:10.1258/096914107782066239 · Cited by 32
Protection of mammography screening against death from breast cancer in women aged 40–64 years
Norman, S. A., Localio, A. R., Weber, A. L., Coates, R. J., Zhou, L. F., Bernstein, L., Malone, K. E., Marchbanks, P. A., Weiss, L. K., Lee, N. C., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9006-8 · Cited by 29
Tumour-related factors and prognosis in breast cancer detected by screening
Olsson, Å., Borgquist, S., Butt, S., Zackrisson, S., Landberg, G., & Manjer, J. (2011) · British journal of surgery · doi:10.1002/bjs.7757 · Cited by 26
An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease
Keyzer‐Dekker, C. M. G., Esch, L. V., Vries, J. D., Ernst, M., Nieuwenhuijzen, G. A. P., Roukema, J. A., & van der Steeg, A. F. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2025-5 · Cited by 25
Estimates of the potential risk of radiation-related cancer from screening in the UK
de González, A. B. (2011) · Journal of Medical Screening · doi:10.1258/jms.2011.011073 · Cited by 22
Puliti, D., Miccinesi, G., & Zappa, M. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1011881 · Cited by 20
Neta, G. I., Anderson, W. F., Gilbert, E. S., & de González, A. B. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1820-8 · Cited by 14
Number Needed to Screen: Appropriate Use of This New Basis for Screening Mammography Guidelines
Feig, S. A. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8320 · Cited by 11
Bakács, T., & Mehrishi, J. N. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-251 · Cited by 10
Suicide Attitude in Breast Cancer Patients
Leo, D. D., Predieri, M., Melodia, C., Vella, J., Forza, G., & de Bertolini, C. (2010) · Psychopathology · doi:10.1159/000284702 · Cited by 8
(1977) · doi:10.1002/1097-0142(197706)39:6<2772::aid-cncr2820390665>3.0.co;2-k
Cited by
International evaluation of an AI system for breast cancer screening
McKinney, S. M., Sieniek, M., Godbole, V., Godwin, J., Antropova, N., Ashrafian, H., Back, T., Chesus, M., Corrado, G. S., Darzi, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1799-6 · Cited by 3,287
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Understanding and misunderstanding randomized controlled trials
Deaton, A., & Cartwright, N. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.005 · Cited by 1,841
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R., Rachet, B., & Aggarwal, A. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30388-0 · Cited by 1,807
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Metadata
- Authors
- Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M.
- Venue
- British Journal of Cancer
- Published
- 2013-06
- Volume
- 108
- Issue
- 11
- Pages
- 2205-2240
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2113622720
- Cited by
- 1,069
- References
- 151
- FWCI
- 32.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.